Danbury Hospital and Norwalk Hospital, both in Connecticut, recently joined NRG Oncology as primary clinical research sites, which means patients at both providers will have expanded access to clinical research as a care option—there are a number of clinical trials now available addressing various cancers.
What is NRG Oncology?
NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing clinical decisions making and healthcare policy. The organization brings together the National Surgical Adjuvant Breast and Bowel Project (NSAB), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)—each recognized internationally as a research leader. NRG Oncology has an extensive background conducting multi-institutional phase II and phase III clinical trials and a history of undertaking phase I and translational biological studies imperative for oncologic research of the future. It sponsors many dozens of studies at any given time.
Connecticut Provider & NRG Oncology Collaboration
The two Connecticut providers will participate in breast cancer, radiation, oncology, and gynecologic cancer studies and treatments.
Both the Connecticut hospitals are part of the rebranded Nuvance Health following the merger between Western Connecticut Health Network and New York-based Health Quest Systems. Nuvance’s announcement noted NRG’s approval demonstrates that both the Connecticut-based hospitals are qualified to participate in clinical research on an international level.
The Nuvance Health System includes several hospitals and:
- Integrated physician practice
- Agency for home care and community health services
- Full-service pharmacy
- Emergency medical services
- Occupational medicine program
Clinical Research as Care Options for Connecticut Residents
The recognition from NRG Oncology adds to the two gynecologic cancer trials the hospitals had recently introduced. Those trials are centered on offering investigational drugs to treat epithelial ovarian, fallopian tube, primary peritoneal and recurrent ovarian cancers.
Nuvance Health Cancer Service Line Comment
Dr. Margo Shoup, chair of the cancer service line for Nuvance Health, declared, “NRG Oncology is a very important organization so it means a lot to be recognized for our cancer research capabilities.” Dr. Shoup continued, “As members of NRG Oncology, our clinicians and researchers will be able to engage with oncology leaders from around the world to further expand their knowledge and then apply advancements to our cancer patients, here at home.”
Dr. Margo Shoup, chair of the cancer service line for Nuvance Health
Call to Action: Do you or a loved one struggle with a diagnosed cancer and live in the Connecticut region? You may want to seek a second opinion at Nuvance Health. If you are a sponsor or CRO thinking about partnering with Nuvance, we offer Dr. Shoup’s contact or TrialSite Network matching services can be utilized.Source: Newswise, Inc.